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ABSTRACT
The laboratory mouse is a key model organism to in-
vestigate mechanism and therapeutics of human dis-
ease. The number of targeted genetic mouse models
of disease is growing rapidly due to high-throughput
production strategies employed by the International
Mouse Phenotyping Consortium (IMPC) and the de-
velopment of new, more efficient genome engineer-
ing techniques such as CRISPR based systems. We
have previously described the European Mouse Mu-
tant Archive (EMMA) resource and how this inter-
national infrastructure provides archiving and dis-
tribution worldwide for mutant mouse strains. EMMA
has since evolved into INFRAFRONTIER (http://www.
infrafrontier.eu), the pan-European research infras-
tructure for the systemic phenotyping, archiving and
distribution of mouse disease models. Here we de-
scribe new features including improved search for
mouse strains, support for new embryonic stem cell
resources, access to training materials via a compre-
hensive knowledgebase and the promotion of inno-
vative analytical and diagnostic techniques.
INTRODUCTION
For over a century, mouse strains have been used as mod-
els to study the genetic, environment and pharmacologi-
cal components of human disease (1). The applicability of
mouse models to translational research is evident in the
growing number ofmutantmouse resources that are becom-
ing available. To date, over 10 000mouse genes have hadmu-
tant alleles described in the literature (2). The International
Mouse Phenotyping Consortium (IMPC) is generating a
knockout mouse strain for every protein-coding gene and
characterising their phenotypes in a broad-based pheno-
typing pipeline (3,4). In conjunction, new technologies are
greatly increasing the efficiency and speed by which mutant
mouse strains are being generated. Especially promising are
techniques using CRISPR/CAS9 endonucleases that target
genes without the need for embryonic stem (ES) cell cultur-
ing and could cut production time for mutant mouse strains
in half or more (5,6).
Mouse repositories play an important role in promot-
ing and distributing the resources produced by both large-
and small-scale mouse projects. In a research era of lim-
ited funding and ethical concern about unnecessary experi-
mental animal production, mouse repositories reduce costs
and duplication by providing high quality mouse strains
with supporting documentation so that researchers do not
need to generate strains of their own. Repositories also fre-
quently provide training and protocols for best practice in
the breeding and experimental use of mouse models. The
European Mouse Mutant Archive (EMMA) is one such
repository that coordinates archiving and distribution of
mice across 16 national partners and provides up to date
information about strain availability. Since the resource was
described in the 2010 NAR database issue (7), EMMA has
merged with the wider INFRAFRONTIER project and
supports standardized mouse phenotyping services in Eu-
rope to ensure results are robust and reproducible. The
merger of the two projects has the expanded goals of:
1. Providing access to mouse models, data and scientific
platforms and services.
2. Determining genotype–phenotype interactions through
cutting-edge analytical and diagnostic methodology in
the INFRAFRONTIER mouse clinics.
3. Archiving and distribution of mouse strains.
Here we present new features and improved architecture
supporting these goals.
NEW INFRAFRONTIER WEB PORTAL HIGHLIGHTS
AVAILABLE SERVICES
The new web portal was built based on user feedback and
reflects the diverse and dynamic nature of the project by
being organized into several distinct sections. A news sec-
tion highlights recent events that are of relevance to the
INRAFRONTIER community and are updated frequently.
Resources and services offered by the project are high-
lighted in boxes containing icons and links that lead users
to detailed pages. The ability to search and browse avail-
able mouse strains is also offered on the home page. At the
top of the page, four drop down menus expand into an ex-
tensive hierarchy that allows users to drill down to features
described below.
Enhanced search for mutant mouse strains
One of our highest priorities is to enhance searching or
browsing for strains (Figure 1). This page underwent ex-
tensive redesign to present only the minimum information
needed for users to find appropriate mouse strains and re-
tains the EMMA logo to provide continuity from the pre-
vious project. User testing and online surveys found that
the three biggest determinants are the (i) gene mutated in
a given strain, (ii) strain names with the allele(s) propa-
gated in the strain and (iii) whether the strain is available
to order. The results table provides this critical data and is
also flexible, returning a disease as described in the Online
Mendelian Inheritance of Man (OMIM) with mouse mod-
els as manually associated by theMouseGenome Informat-
ics (MGI) at Jackson Laboratory based on authors’ asser-
tions in the scientific literature (2). Each search creates a
new tab on the results table so that users can compare re-
sults from multiple searches. Tabs also contain interfaces
to browse by mouse strain based on disease models, gene
symbol and by allele type. As availability status of strains is
determined by a number of factors, we use the simple visu-
alisation of the familiar red, yellow, green traffic light icons
that represent ‘under development’, ‘only a small colony is
available’ and ‘lines available to order’. A user can click on
the plus icon in a result row and a new menu is presented
that includes an extensive array of secondary information
related to a strain including husbandry information, mate-
rial transfer agreement (MTA) or licensing documents (if
any) and pricing (Figure 1).
As of August 2014, the INFRAFRONTIER resource
contains over 4178 submitted strains from 21 countries in-
cluding 2052 lines generated by high-throughput projects
such as the IMPC.Of these strains, over 1465 (3656 requests
from 42 countries for 1465 individual strains) have been re-
quested from researchers worldwide. While the majority of
orders come fromwithin Europe, a significant percentage of
orders come from North America (32%) and Asia (15%).
Online strain submission tool
About half of the strains available from the INFRAFRON-
TIER resource come from smaller scale projects and indi-
vidual labs that deposit strains to make available to oth-
ers. As the information needed is quite extensive and broad
ranging, an online wizard has been developed that guides
users through an 11-step process (Figure 2). An email ad-
dress is requested in step 1 to act as a unique identifier
that can recall previous submissions that were started but
not completed. Specific tools are incorporated into the wiz-
ard including the ability to navigate to previous steps, pull
down menus of commonly used ES cell lines and genetic
background provided fromMGI, and automated metadata
annotation when a PubMed or OMIM ID is given. Upon
successful completion, a PDF summarising the information
given is emailed back to the submitter.
The Netherlands Cancer Institute embryonic stem cells
archive
Another new service that INFRAFRONTIER provides is
the distribution of mutant mouse embryonic stem cells
(ESC) derived from validated genetically engineered mouse
models (GEMM-ESCs) of cancer created by the Nether-
lands Cancer Institute (NKI) (8). Breeding of cancer mouse
models is difficult as they typically involve multiple dom-
inant alleles that do not necessarily co-segregate and thus
need to be genotyped at each step of breeding. The NKI
GEMM-ESCs addresses this challenge by providing ESC
that carry common oncogenic alleles and include additional
genomic landing sites for easy insertion of new oncogenic
or tumour-suppressor transgenes. From a dedicated section
of the INFRAFRONTIER portal, users can order ES cell
clones, download MTAs, find maps of the mutant alleles
and obtain protocols for culturing the cells and inserting
transgenes.
Promotion of training courses
INFRAFRONTIER through its partners offers a wide
range of state-of-the-art training opportunities includ-
ing popular cryopreservation courses and best practices
for broad-based mouse phenotyping. The INFRAFRON-
TIER web portal promotes upcoming training events
through dedicated web pages, news bulletins and related
protocols being stored in the knowledgebase.
Free production and phenotyping of mouse strains
Free mouse strain production and broad-based phenotyp-
ing are provided to eligible partners in a series of compet-
itive calls. Information and applications are available from
the INFRAFRONTIER portal and outreach is performed
via an INFRAFRONTIER contact list as well as other
sources.
Axenic services
Mice derived by aseptic techniques and reared and main-
tained under germ-free conditions are important research
tools for immunological and microbiome studies. This ser-
vice was previously offered as part of EMMA and now in-
cludes rich documentation on the facility supporting this
service, key references and a request form.
Rich, navigable knowledgebase
Through its diverse activities, INFRAFRONTIER
has developed a rich knowledgebase with five broad
categories––protocols, bibliography, workshops and policy
documents. An easy to navigate hierarchy with the ability
to drill down to specific documents and other media is
included as part of the knowledgebase. As these documents
are core to the training activities, they are frequently
updated and represent the state of the art. Presentations
from INFRAFRONTIER workshops are also available
allowing users to stay informed of diverse subject manners
that are the focus of these workshops. A Drupal framework
for the portal provides a Wiki-like interface to facilitate
Figure 1. INFRAFRONTIER strain search. A simplified grid summing up available mouse strains is returned based on lexical matching. Rows are ex-
panded when the plus icon is selected, giving summaries on a wide range of data available for a strain.
addition of content by non-technical personnel so that
users may be quickly informed about news, events and have
access to the latest protocols within the knowledgebase.
INTEROPERABILITY AND SUSTAINABILITY
High-throughput mouse production by IMPC centres is a
quickly growing source ofmouse strains. Extensive develop-
ment has gone into an automated curation procedure that
uses IMPC tracking information to populate the database
when a strain is to be distributed by INFRAFRONTIER.
The data collected include the ES cell clone used to gen-
erate the mouse strain, the mutant allele, the genetic back-
ground and the distribution centre. From this information,
a customized algorithm incorporates the allele and genetic
background of contributing strains to automatically gen-
erate strain nomenclature. This algorithm is frequently re-
viewed and modified to reflect procedural chances in mouse
strain production.
Extensive expert curation takes place to correct, stan-
dardize and complete the original data provided by the ex-
ternal submitters, taking advantage of new and efficient
curation interfaces. These interfaces use official nomencla-
ture for gene, allele, transgene, background names and sym-
bols and help identify when new gene or allele nomen-
clature is needed. The curation is based on the applica-
tion of rules and guidelines established by the Interna-
tional Committee on Standardized Genetic Nomenclature
for Mice (http://www.informatics.jax.org/mgihome/nomen)
for the initial assignment and periodic review and update of
strain nomenclature.
Our effort to assign proper nomenclature to mouse al-
leles and strains facilitates coordination with other re-
sources. Mechanisms have been introduced to ensure
gene and allele nomenclature is up to date by obtain-
ing the latest nomenclature from MGI. Preliminary strain
designations made by INFRAFRONTIER curators are
submitted, weekly reviewed and subsequently promoted
by the International Mouse Strain Resource (9). In a
similar manner, the IMPC portal generates links from
gene pages to corresponding INFRAFRONTIER mutant
Figure 2. Online strain submission tool. An online tool guides users through a series of steps to upload data about a strain they wish to deposit in the
EMMA resource. Screenshot depicts the step where genotype information is entered. The use of pull down menus reduces user errors and curation burden.
strains based on shared identifiers. Standardized strain
nomenclature also allows users to find phenotype associ-
ations for a given strain when it is described in the liter-
ature. This facilitates comparisons of phenotypes for re-
lated strains studied by multiple resources to ensure asso-
ciations are robust and reproducible. For example, Nbeal2
mutant mice distributed by INFRAFRONTIER (strain
B6NTac;B6N-Atm1Brd Nbeal2tm1a(EUCOMM)Wtsi/WtsiCnbc)
are characterized by the IMPC as having increased platelet
size and decreased circulating platelet cell numbers (http://
www.mousephenotype.org/data/genes/MGI:2448554). This
is similar to a published report about a different mutant
strain that describes Nbeal2 deficient mice as having defec-
tive platelet development and function, and being a strong
candidate model for the human disease grey platelet syn-
drome (GPS) (10). Because both strains have been anno-
tated with the Mammalian Phenotype ontology (11,12), a
researcher can be reasonably confident that the Nbeal2 de-
ficient strain from INFRAFRONTIERwill recapitulate the
phenotypes and be a model for GPS. In fact, there are sev-
eral on-going efforts to systematically score models based
on shared phenotype features with human disease patients
(13,14). Such approaches will better inform users about
which strains they need and IMPC phenotypes and disease
modelling scores maybe included in future updates of the
INFRAFRONTIER portal.
Interoperability promotes uptake and use of IN-
FRAFRONTIER resources, a critical factor in sustain-
ability. Another factor is the stability of funding. The
INFRAFRONTIER GmbH was created to coordinate the
transnational activities of INFRAFRONTIER. With the
involvement and financial commitment of the members
states that have founded the GmbH, a new level of financial
sustainability and planning reliability is in place, ensuring
that INFRAFRONTIER will be able to continue its
mission of serving the worldwide scientific community.
CONCLUSIONS
INFRAFRONTIER provides many resources supporting
translational research including the archiving and distribu-
tion of mouse disease models, a rich knowledgebase, and
training of a new generation of researchers in the use and
production ofmousemodels of disease. Emerging technolo-
gies promise to greatly increase gene–disease associations
and the ability to make relevant mouse disease models. IN-
FRAFRONTIER is in a unique position to scale up in par-
allel with this increased output and allow scientists to find
the resources needed to support their research for many
years to come.
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